摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,5-bis(4-chlorobenzylidene)-1-ethylpiperidin-4-one | 7140-87-6

中文名称
——
中文别名
——
英文名称
3,5-bis(4-chlorobenzylidene)-1-ethylpiperidin-4-one
英文别名
3,5-bis-(4-chloro-benzylidene)-1-ethyl-piperidin-4-one;1-Ethyl-3,5-bis-(p-chlorbenzyliden)-4-piperidon;3,5-Bis[(4-chlorophenyl)methylidene]-1-ethylpiperidin-4-one
3,5-bis(4-chlorobenzylidene)-1-ethylpiperidin-4-one化学式
CAS
7140-87-6
化学式
C21H19Cl2NO
mdl
MFCD06328732
分子量
372.294
InChiKey
HZDYQVUKYVCQRS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.3
  • 重原子数:
    25
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    20.3
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    2-氨基-4-甲基噻唑3,5-bis(4-chlorobenzylidene)-1-ethylpiperidin-4-one溶剂黄146 作用下, 反应 20.0h, 以55%的产率得到C25H23Cl2N3S
    参考文献:
    名称:
    Substituted thiazoles V. Synthesis and antitumor activity of novel thiazolo[2,3-b]quinazoline and pyrido[4,3-d]thiazolo[3,2-a]pyrimidine analogues
    摘要:
    A novel series of thiazolo[2,3-b]quinazoline (14-23, 26 and 27), and pyrido[4,3-d]thiazolo[3,2-a] pyrimidine (34-43, 45 and 46) analogues were designed and synthesized. The obtained compounds were evaluated for their in-vitro antitumor activity at the National Cancer Institute (NCI) 60 cell lines panel assay. Compounds 22, 38, 40 and 41 showed remarkable broad-spectrum antitumor activity. Compounds 22 and 38 are almost nine fold more active than 5-FU, with GI(50), TGI, and LC50 values of 2.5, >100, >100; and 2.4, 9.1, 36.2 mu M, respectively; while 40 and 41 are almost seven fold more active than 5-FU, with GI(50), TGI, and LC50 values of 2.9, 12.4, 46.6 and 3.0, 16.3, 54.0 mu M, respectively. (C) 2011 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2011.10.023
  • 作为产物:
    描述:
    N-乙基-4-哌啶酮4-氯苯甲醛 在 potassium hydroxide 作用下, 以 乙醇 为溶剂, 生成 3,5-bis(4-chlorobenzylidene)-1-ethylpiperidin-4-one
    参考文献:
    名称:
    吲哚类抗肿瘤药的合成和分子建模研究†
    摘要:
    吲哚基化合物30-63是通过1-烷基-3,5-双(亚芳基)-4-哌啶酮11-25的多组分1,3-偶极环加成反应与偶氮甲亚胺(通过缩合生成)而合成的靛红26-28与肌氨酸29)。46和48的单晶X射线研究支持了反应的区域选择性和立体选择性。通过体外磺基罗丹明B生物测定,大多数合成的螺吲哚均显示出对HeLa(宫颈癌)细胞系的有效抗肿瘤特性,高于顺铂。只有化合物54表现出对HepG2(肝细胞癌)细胞系的生物效价,可与盐酸阿霉素(标准参考)媲美。使用3D药效基团和2D-QSAR研究来验证观察到的生物学数据并确定控制活性的最重要参数。从计算研究中估计的生物性质显示出对实验数据的高度近似。
    DOI:
    10.1039/c6ra07061b
点击查看最新优质反应信息

文献信息

  • Substituted thiazoles V. Synthesis and antitumor activity of novel thiazolo[2,3-b]quinazoline and pyrido[4,3-d]thiazolo[3,2-a]pyrimidine analogues
    作者:Fatmah A.M. Al-Omary、Ghada S. Hassan、Shahenda M. El-Messery、Hussein I. El-Subbagh
    DOI:10.1016/j.ejmech.2011.10.023
    日期:2012.1
    A novel series of thiazolo[2,3-b]quinazoline (14-23, 26 and 27), and pyrido[4,3-d]thiazolo[3,2-a] pyrimidine (34-43, 45 and 46) analogues were designed and synthesized. The obtained compounds were evaluated for their in-vitro antitumor activity at the National Cancer Institute (NCI) 60 cell lines panel assay. Compounds 22, 38, 40 and 41 showed remarkable broad-spectrum antitumor activity. Compounds 22 and 38 are almost nine fold more active than 5-FU, with GI(50), TGI, and LC50 values of 2.5, >100, >100; and 2.4, 9.1, 36.2 mu M, respectively; while 40 and 41 are almost seven fold more active than 5-FU, with GI(50), TGI, and LC50 values of 2.9, 12.4, 46.6 and 3.0, 16.3, 54.0 mu M, respectively. (C) 2011 Elsevier Masson SAS. All rights reserved.
  • Synthesis and molecular modeling studies of indole-based antitumor agents
    作者:Riham F. George、Siva S. Panda、El-Sayed M. Shalaby、Aladdin M. Srour、I. S. Ahmed Farag、Adel S. Girgis
    DOI:10.1039/c6ra07061b
    日期:——
    3-dipolar cycloaddition reaction of 1-alkyl-3,5-bis(arylidene)-4-piperidones 11–25 with azomethine ylides (generated by the condensation of isatins 26–28 with sarcosine 29). The single crystal X-ray studies of 46 and 48 supported the regio- and stereoselectivity of the reaction. Most of the synthesized spiro-indoles exhibited potent antitumor properties against the HeLa (cervical cancer) cell line through
    吲哚基化合物30-63是通过1-烷基-3,5-双(亚芳基)-4-哌啶酮11-25的多组分1,3-偶极环加成反应与偶氮甲亚胺(通过缩合生成)而合成的靛红26-28与肌氨酸29)。46和48的单晶X射线研究支持了反应的区域选择性和立体选择性。通过体外磺基罗丹明B生物测定,大多数合成的螺吲哚均显示出对HeLa(宫颈癌)细胞系的有效抗肿瘤特性,高于顺铂。只有化合物54表现出对HepG2(肝细胞癌)细胞系的生物效价,可与盐酸阿霉素(标准参考)媲美。使用3D药效基团和2D-QSAR研究来验证观察到的生物学数据并确定控制活性的最重要参数。从计算研究中估计的生物性质显示出对实验数据的高度近似。
查看更多